Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

NCT04723602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Ebola Virus Disease
Marburg Virus Disease

Interventions

BIOLOGICAL: cAd3-Marburg
BIOLOGICAL: cAd3-EBO-S

Sponsor

Albert B. Sabin Vaccine Institute

Collaborators

[object Object]
[object Object]